Hostname: page-component-745bb68f8f-cphqk Total loading time: 0 Render date: 2025-02-11T04:55:40.171Z Has data issue: false hasContentIssue false

Observations In Hypoglycaemia: V. Disorders of Speech

Published online by Cambridge University Press:  08 February 2018

E. Stengel
Affiliation:
From the Department of Clinical Research, Crichton Royal, Dumfries
W. Mayer-Gross
Affiliation:
From the Department of Clinical Research, Crichton Royal, Dumfries
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

During the hypoglycaemia produced by insulin for the treatment of psychoses, disorders of speech occur as symptoms of the dissolution and restitution of cerebral function. Although transitory, they can be observed accurately, as the hypoglycaemic condition is repeated daily for weeks in the same patient. They have in fact been studied and commented on by several workers since the method was initiated by Sakel in 1934; we shall refer later to some of the findings and views in the literature. In this paper an attempt will be made to describe and classify the various speech disorders, and to relate their characteristic features to other hypoglycaemie symptoms occurring at the same time. Attention will be drawn to certain speech-like symptoms which hitherto have been scarcely noticed. The possible influence of the underlying psychosis will also have to be considered.

Type
Part I.—Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1945 

References

Angyal, L. (1937), Z. ges. Neurol. Psychiat., 106, 662.Google Scholar
Bonhoeffer, K. (1898), Die Geistesstörungen der Alkoholdeliranten. Breslau.Google Scholar
Hemphill, R. E. (1940), J. Ment. Sci., 86, 799.CrossRefGoogle Scholar
Jackson, Hughlings (1932), Selected Writings, vol. i, ed. Taylor, J. London.Google Scholar
Kleist, K. (1925), Allg. Z. Psychiat., 82.Google Scholar
Kojevnikov, (1895), Neurol. Centralbl., 14.Google Scholar
Mayer-Gross, W. (1941), J. Ment. Sci., 87, 157.Google Scholar
Idem (1943), Proc. Roy. Soc. Med., 36, 343.Google Scholar
Paterson, A. (1944), ibid., 37, 556.Google Scholar
Sakel, M. (1938), Pharmacol. Treatment of Schizophrenia. New York and Washington.Google Scholar
Stengel, E. (1937), Mon. Psychiat. Neurol., 95, 129.Google Scholar
Symonds, C. P. (1937), Proc. Roy. Soc. Med., 30, 1081.Google Scholar
Wilson, , Kinnier, S. A. (1940), Neurology, vol. ii, p. 1489. Arnold, London.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.